Adequan I.a.
Loading...Adequan I.a. Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Do not use in horses intended for human consumption.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Adequan is recommended for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal joint in horses.
History
There is currently no drug history available for this drug.
Other Information
Each milliliter of Adequan contains 250 mg of Polysulfated Glycosaminoglycan and Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid added when necessary to adjust pH.
Sources
Adequan I.a. Manufacturers
-
Luitpold Pharmaceuticals, Inc.
![Adequan I.a. (Polysulfated Glycosaminoglycan) Injection, Solution [Luitpold Pharmaceuticals, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Adequan I.a. | Luitpold Pharmaceuticals, Inc.
The recommended dose of Adequan in horses is 250 mg (1 vial) once a week for five weeks, intra-articularly. The joint area must be shaved, cleansed and sterilized as in a surgical procedure prior to injection. Do not mix Adequan with other drugs or solvents.
Login To Your Free Account